BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 20972336)

  • 1. Infusion of mature megakaryocytes into mice yields functional platelets.
    Fuentes R; Wang Y; Hirsch J; Wang C; Rauova L; Worthen GS; Kowalska MA; Poncz M
    J Clin Invest; 2010 Nov; 120(11):3917-22. PubMed ID: 20972336
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative analysis of human ex vivo-generated platelets vs megakaryocyte-generated platelets in mice: a cautionary tale.
    Wang Y; Hayes V; Jarocha D; Sim X; Harper DC; Fuentes R; Sullivan SK; Gadue P; Chou ST; Torok-Storb BJ; Marks MS; French DL; Poncz M
    Blood; 2015 Jun; 125(23):3627-36. PubMed ID: 25852052
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induced Pluripotent Stem Cell-Derived Megakaryocytes and Platelets for Disease Modeling and Future Clinical Applications.
    Borst S; Sim X; Poncz M; French DL; Gadue P
    Arterioscler Thromb Vasc Biol; 2017 Nov; 37(11):2007-2013. PubMed ID: 28982668
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanisms of thrombocytopenia in platelet-type von Willebrand disease.
    Bury L; Malara A; Momi S; Petito E; Balduini A; Gresele P
    Haematologica; 2019 Jul; 104(7):1473-1481. PubMed ID: 30655369
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Caspase-9 mediates the apoptotic death of megakaryocytes and platelets, but is dispensable for their generation and function.
    White MJ; Schoenwaelder SM; Josefsson EC; Jarman KE; Henley KJ; James C; Debrincat MA; Jackson SP; Huang DC; Kile BT
    Blood; 2012 May; 119(18):4283-90. PubMed ID: 22294729
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhancing functional platelet release in vivo from in vitro-grown megakaryocytes using small molecule inhibitors.
    Jarocha D; Vo KK; Lyde RB; Hayes V; Camire RM; Poncz M
    Blood Adv; 2018 Mar; 2(6):597-606. PubMed ID: 29545255
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Infused factor VIII-expressing platelets or megakaryocytes as a novel therapeutic strategy for hemophilia A.
    Lyde RB; Ahn HS; Vo KK; Jarocha DJ; Tkaczynski J; Treffeisen E; Sullivan SK; Camire RM; Sabatino DE; French DL; Poncz M
    Blood Adv; 2019 May; 3(9):1368-1378. PubMed ID: 31036722
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unraveling mechanisms that control platelet production.
    Italiano JE
    Semin Thromb Hemost; 2013 Feb; 39(1):15-24. PubMed ID: 23266965
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Highly efficient platelet generation in lung vasculature reproduced by microfluidics.
    Zhao X; Alibhai D; Walsh TG; Tarassova N; Englert M; Birol SZ; Li Y; Williams CM; Neal CR; Burkard P; Cross SJ; Aitken EW; Waller AK; Beltrán JB; Gunning PW; Hardeman EC; Agbani EO; Nieswandt B; Hers I; Ghevaert C; Poole AW
    Nat Commun; 2023 Jul; 14(1):4026. PubMed ID: 37419900
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sustained thrombocytopenia in mice: serial studies of megakaryocytes and platelets.
    Stenberg PE; Levin J; Corash L
    Exp Hematol; 1990 Feb; 18(2):124-32. PubMed ID: 2303104
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ADAP deficiency impairs megakaryocyte polarization with ectopic proplatelet release and causes microthrombocytopenia.
    Spindler M; van Eeuwijk JMM; Schurr Y; Nurden P; Nieswandt B; Stegner D; Reinhold A; Bender M
    Blood; 2018 Aug; 132(6):635-646. PubMed ID: 29950291
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Turbulence Activates Platelet Biogenesis to Enable Clinical Scale Ex Vivo Production.
    Ito Y; Nakamura S; Sugimoto N; Shigemori T; Kato Y; Ohno M; Sakuma S; Ito K; Kumon H; Hirose H; Okamoto H; Nogawa M; Iwasaki M; Kihara S; Fujio K; Matsumoto T; Higashi N; Hashimoto K; Sawaguchi A; Harimoto KI; Nakagawa M; Yamamoto T; Handa M; Watanabe N; Nishi E; Arai F; Nishimura S; Eto K
    Cell; 2018 Jul; 174(3):636-648.e18. PubMed ID: 30017246
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thrombopoietic effect of VPAC1 inhibition during megakaryopoiesis.
    Peeters K; Loyen S; Van Kerckhoven S; Stoffels K; Hoylaerts MF; Van Geet C; Freson K
    Br J Haematol; 2010 Oct; 151(1):54-61. PubMed ID: 20735399
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RUNX1-deficient human megakaryocytes demonstrate thrombopoietic and platelet half-life and functional defects.
    Lee K; Ahn HS; Estevez B; Poncz M
    Blood; 2023 Jan; 141(3):260-270. PubMed ID: 36219879
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization and transplantation of induced megakaryocytes from hematopoietic stem cells for rapid platelet recovery by a two-step serum-free procedure.
    Chen TW; Hwang SM; Chu IM; Hsu SC; Hsieh TB; Yao CL
    Exp Hematol; 2009 Nov; 37(11):1330-1339.e5. PubMed ID: 19664680
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Measurement of thrombopoietic activity through the quantification of megakaryocytes in bone marrow cytology and reticulated platelets.
    Silva LF; Golim MA; Takahira RK
    Res Vet Sci; 2012 Aug; 93(1):313-7. PubMed ID: 21820687
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RhoA is essential for maintaining normal megakaryocyte ploidy and platelet generation.
    Suzuki A; Shin JW; Wang Y; Min SH; Poncz M; Choi JK; Discher DE; Carpenter CL; Lian L; Zhao L; Wang Y; Abrams CS
    PLoS One; 2013; 8(7):e69315. PubMed ID: 23935982
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuraminidase-induced thrombocytopenia in mice: effects on thrombopoiesis.
    Stenberg PE; Levin J; Baker G; Mok Y; Corash L
    J Cell Physiol; 1991 Apr; 147(1):7-16. PubMed ID: 2037624
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Megakaryocyte modification of platelets in thrombocytopenia.
    Roweth HG; Parvin S; Machlus KR
    Curr Opin Hematol; 2018 Sep; 25(5):410-415. PubMed ID: 29985173
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Are there more tricks in the bag for treating thrombocytopenia?
    Leavitt AD
    J Clin Invest; 2010 Nov; 120(11):3807-10. PubMed ID: 20972327
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.